Molecular Diagnostics
Multi-Omics Approach Guides Relapsed Multiple Myeloma Treatment
Many patients with relapsed multiple myeloma are not often matched with correct treatment options in a timely or personalized manner, and most patients have a median survival rate of six years. With standard diagnosis and treatment, relapses are usually inevitable and fatal for most patients. More...30 Aug 2018
Whole-Genome Sequencing Diagnoses Early Infantile Epileptic Encephalopathy
Early infantile epileptic encephalopathy (EIEE) is a rare epilepsy syndrome that causes intractable seizures with multiple seizure types and presents in the first months of life. While the prevalence of EIEE is unclear, and only affects a subset of all infants with seizures, infants with EIEE have serious medical complications. More...30 Aug 2018
DNA Screening and Invasive Testing Show Similar Miscarriage Rates
Cell-free DNA (cfDNA) tests are increasingly being offered to women in the first trimester of pregnancies at a high risk of trisomy 21 to decrease the number of required invasive fetal karyotyping procedures and their associated miscarriages. More...29 Aug 2018
Genotyping Assay Integrated into Glioma Treatment
Stage II diffuse gliomas are normally challenging to identify using intraoperative histologic methods because of their location, infiltrative growth, low cellularity, and small stereotactic biopsy size. Diagnosis often requires the patient to undergo multiple neurosurgical procedures to collect tumor tissue samples. More...22 Aug 2018
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
Blood Glucose Test Strip
AutoSense Test
Gold Member
Automatic Hematology Analyzer
DH-800 Series
In Other News
Genetic Mutation Identified in Childhood Brain Disorder
Biomarker-Based Blood Test Developed for Early Cancer Diagnosis
Genetic Testing for Hypercholesterolemia Improves Diagnosis
Epigenetic Diagnostic Tool Detects Diseases in Newborns
New Glioma Test Provides Answers during Surgical Procedures
Gene Test Distinguishes Kawasaki Disease from Other Illnesses
Urine Test Accurately Detects Bladder Cancer Recurrence
FDA Clears Diagnostic Assay for Group B Strep
Infections Defined in Urothelial Bladder Tumors
Fracture Risk Predicted with New Genetic Screen
Susceptible Genes Identified for Childhood Kidney Disease
Mutations Identified As Cause for Rare Bone Marrow Disorder
New Troponin Assays Receive US Marketing Clearance
MicroRNA Panel Delivers Thyroid Cancer Diagnosis
Genetic Alterations Correlated to Aggressive Prostate Cancer
DNA Methylation Linked to Depression in Middle-Aged and Elderly
New Target Protein for Colon Cancer Identified
Neuro Disorders Involving Epilepsy Include Distinct De Novo Variants
Sequencing Produces Better Diagnostics for Pediatric Genetic Disease
Biomarker Detects Active Melanoma and Predicts Survival
Acute Myeloid Leukemia Risk Predicted in Healthy Individuals
Biosensor Chip Detects SNPs with Higher Sensitivity
Cancer Genetics Highlight Mutations Linked to Drug Response
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.